Author
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from the month of April 2021.
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from the month of March 2021.
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from the month of February 2021.
Topics range from an analysis of recent developments in drug-pricing transparency, to an analysis of state-level drug product selection laws.
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from the month of December.
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from November 2020.
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from October 2020.
Selections feature topics ranging from political pressures facing the FDA, to the financial incentive structure for antibiotic development.
Interesting empirical studies, policy analyses, and editorials on pharma, health law, and policy issues from August 2020.
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from July 2020.
